The potential public health impact of Herpes Zoster vaccination in the 65 years of age cohort in Italy

Herpes Zoster (HZ) presents a considerable public health burden in Italy among people aged ≥50 years. This study aimed to assess the clinical and economic impact of HZ vaccination in the 65 years of age (YOA) cohort in Italy, by comparing the new Adjuvanted Recombinant Zoster Vaccine (RZV) with the...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Hum Vaccin Immunother
Autors principals: Volpi, Antonio, Boccalini, Sara, Dari, Silvia, Clarke, Christopher, Curran, Desmond, Loiacono, Idalba, Pitrelli, Andrea, Puggina, Anna, Tosatto, Roberta, Van Oorschot, Desirée, Franco, Elisabetta
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2019
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7062451/
https://ncbi.nlm.nih.gov/pubmed/31442095
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2019.1657753
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars